Crinetics Pharmaceuticals Inc.
Clinical trials sponsored by Crinetics Pharmaceuticals Inc., explained in plain language.
-
New pill shows promise for controlling acromegaly Long-Term
Disease control OngoingThis study looks at the long-term safety and effectiveness of an oral medication called paltusotine for people with acromegaly, a condition where the body makes too much growth hormone. Participants are adults who have already completed a related study. The goal is to see if the …
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 10:29 UTC
-
Could a daily pill replace monthly shots for acromegaly?
Disease control OngoingThis study tests an oral drug called paltusotine for people with acromegaly, a condition where the body makes too much growth hormone. Participants who were stable on standard injectable treatments either switched to paltusotine or a placebo. The goal is to see if the pill can ke…
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New pill could tame rare growth disorder without needles
Disease control OngoingThis study tests a once-daily pill called paltusotine for people with acromegaly, a condition where the body makes too much growth hormone. The goal is to see if the drug can safely lower hormone levels to normal. About 111 adults who are not on other treatments will be randomly …
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC